Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02851563 · ClinicalTrials.gov registry record
A Natural History Study of Canavan Disease
A clinical trial of Canavan Disease, sponsored by NYU Langone Health.
- Completed
- Registry status
- 21
- Enrollment target
- 3
- Study locations
NCT02851563 is a study of Canavan Disease that has completed, run by NYU Langone Health. The registered enrollment target is 21 participants. The trial reports 3 study locations across 3 states.
The verdict
NCT02851563, a study of Canavan Disease, has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
- 3
- Study locations
Study Summary
The purpose of this study is to learn more about the natural history of Canavan disease
Conditions Studied
Study Locations (3)
Massachusetts
- Massachusetts General Hospital - Boston
New York
- NYU Langone Medical Center - New York
Other
- University Medical Center Hamburg-Eppendorf - Hamburg
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2016-05 |
| Est. Completion | 2019-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02851563
The ClinicalTrials.gov registry entry for NCT02851563 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Canavan Disease appearing as the primary indexed condition, and to 0 interventions.
NCT02851563 reports 3 study locations spanning 3 distinct geographic areas - top geographies include Massachusetts, New York, Other.
Frequently Asked Questions
What is clinical trial NCT02851563 about?
NCT02851563 is a clinical study titled "A Natural History Study of Canavan Disease". The purpose of this study is to learn more about the natural history of Canavan disease
What is the current status of trial NCT02851563?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2016-05. Estimated completion is 2019-04.
What conditions does trial NCT02851563 study?
This clinical trial studies the following conditions: Canavan Disease.
Who is sponsoring clinical trial NCT02851563?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02851563 being conducted?
This trial has 3 study locations across Massachusetts, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Canavan Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.